JPS632927B2 - - Google Patents
Info
- Publication number
- JPS632927B2 JPS632927B2 JP59071507A JP7150784A JPS632927B2 JP S632927 B2 JPS632927 B2 JP S632927B2 JP 59071507 A JP59071507 A JP 59071507A JP 7150784 A JP7150784 A JP 7150784A JP S632927 B2 JPS632927 B2 JP S632927B2
- Authority
- JP
- Japan
- Prior art keywords
- acid
- bath
- carbonate
- weakly acidic
- yokuinin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000654 additive Substances 0.000 claims description 20
- 239000002253 acid Substances 0.000 claims description 15
- 230000002378 acidificating effect Effects 0.000 claims description 15
- 239000000284 extract Substances 0.000 claims description 13
- 230000000996 additive effect Effects 0.000 claims description 12
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 9
- 239000009538 yokuinin Substances 0.000 claims description 8
- 210000002374 sebum Anatomy 0.000 claims description 7
- 230000028327 secretion Effects 0.000 claims description 7
- 238000003287 bathing Methods 0.000 claims description 4
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 3
- 239000000194 fatty acid Substances 0.000 claims description 3
- 229930195729 fatty acid Natural products 0.000 claims description 3
- -1 fatty acid cholesteryl ester Chemical class 0.000 claims description 3
- 125000001931 aliphatic group Chemical group 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 230000017531 blood circulation Effects 0.000 description 7
- 239000001569 carbon dioxide Substances 0.000 description 7
- 229910002092 carbon dioxide Inorganic materials 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 239000007789 gas Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 229940093915 gynecological organic acid Drugs 0.000 description 4
- 150000007524 organic acids Chemical class 0.000 description 4
- 235000005985 organic acids Nutrition 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000001530 fumaric acid Substances 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- ROBFUDYVXSDBQM-UHFFFAOYSA-N hydroxymalonic acid Chemical compound OC(=O)C(O)C(O)=O ROBFUDYVXSDBQM-UHFFFAOYSA-N 0.000 description 2
- QQVIHTHCMHWDBS-UHFFFAOYSA-N isophthalic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=C1 QQVIHTHCMHWDBS-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- WLJVNTCWHIRURA-UHFFFAOYSA-N pimelic acid Chemical compound OC(=O)CCCCCC(O)=O WLJVNTCWHIRURA-UHFFFAOYSA-N 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- RWPGFSMJFRPDDP-UHFFFAOYSA-L potassium metabisulfite Chemical compound [K+].[K+].[O-]S(=O)S([O-])(=O)=O RWPGFSMJFRPDDP-UHFFFAOYSA-L 0.000 description 2
- 229940043349 potassium metabisulfite Drugs 0.000 description 2
- 235000010263 potassium metabisulphite Nutrition 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- ARCGXLSVLAOJQL-UHFFFAOYSA-N trimellitic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C(C(O)=O)=C1 ARCGXLSVLAOJQL-UHFFFAOYSA-N 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- RBNPOMFGQQGHHO-UHFFFAOYSA-N -2,3-Dihydroxypropanoic acid Natural products OCC(O)C(O)=O RBNPOMFGQQGHHO-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- VBSTXRUAXCTZBQ-UHFFFAOYSA-N 1-hexyl-4-phenylpiperazine Chemical compound C1CN(CCCCCC)CCN1C1=CC=CC=C1 VBSTXRUAXCTZBQ-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical class CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
- FEWFXBUNENSNBQ-UHFFFAOYSA-N 2-hydroxyacrylic acid Chemical compound OC(=C)C(O)=O FEWFXBUNENSNBQ-UHFFFAOYSA-N 0.000 description 1
- WLJVXDMOQOGPHL-PPJXEINESA-N 2-phenylacetic acid Chemical compound O[14C](=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-PPJXEINESA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical class OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- RBNPOMFGQQGHHO-UWTATZPHSA-N D-glyceric acid Chemical compound OC[C@@H](O)C(O)=O RBNPOMFGQQGHHO-UWTATZPHSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010016352 Feeling of relaxation Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- JACRWUWPXAESPB-QMMMGPOBSA-N Tropic acid Natural products OC[C@H](C(O)=O)C1=CC=CC=C1 JACRWUWPXAESPB-QMMMGPOBSA-N 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- VLSMHEGGTFMBBZ-UHFFFAOYSA-N alpha-Kainic acid Natural products CC(=C)C1CNC(C(O)=O)C1CC(O)=O VLSMHEGGTFMBBZ-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- PRKQVKDSMLBJBJ-UHFFFAOYSA-N ammonium carbonate Chemical compound N.N.OC(O)=O PRKQVKDSMLBJBJ-UHFFFAOYSA-N 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000000498 cooling water Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- RZKNJSIGVZOHKZ-UHFFFAOYSA-N diazanium carbonic acid carbonate Chemical compound [NH4+].[NH4+].OC(O)=O.OC(O)=O.[O-]C([O-])=O RZKNJSIGVZOHKZ-UHFFFAOYSA-N 0.000 description 1
- 150000001991 dicarboxylic acids Chemical class 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- TUCSOESCAKHLJM-UHFFFAOYSA-L dipotassium carbonic acid carbonate Chemical compound [K+].[K+].OC(O)=O.OC(O)=O.[O-]C([O-])=O TUCSOESCAKHLJM-UHFFFAOYSA-L 0.000 description 1
- CQAIPTBBCVQRMD-UHFFFAOYSA-L dipotassium;phosphono phosphate Chemical compound [K+].[K+].OP(O)(=O)OP([O-])([O-])=O CQAIPTBBCVQRMD-UHFFFAOYSA-L 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 235000019820 disodium diphosphate Nutrition 0.000 description 1
- GYQBBRRVRKFJRG-UHFFFAOYSA-L disodium pyrophosphate Chemical compound [Na+].[Na+].OP([O-])(=O)OP(O)([O-])=O GYQBBRRVRKFJRG-UHFFFAOYSA-L 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 229940005740 hexametaphosphate Drugs 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- VLSMHEGGTFMBBZ-OOZYFLPDSA-N kainic acid Chemical compound CC(=C)[C@H]1CN[C@H](C(O)=O)[C@H]1CC(O)=O VLSMHEGGTFMBBZ-OOZYFLPDSA-N 0.000 description 1
- 229950006874 kainic acid Drugs 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 239000010446 mirabilite Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- LNOPIUAQISRISI-UHFFFAOYSA-N n'-hydroxy-2-propan-2-ylsulfonylethanimidamide Chemical compound CC(C)S(=O)(=O)CC(N)=NO LNOPIUAQISRISI-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 229940093956 potassium carbonate Drugs 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 229940086066 potassium hydrogencarbonate Drugs 0.000 description 1
- BHZRJJOHZFYXTO-UHFFFAOYSA-L potassium sulfite Chemical compound [K+].[K+].[O-]S([O-])=O BHZRJJOHZFYXTO-UHFFFAOYSA-L 0.000 description 1
- 235000019252 potassium sulphite Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 229940001584 sodium metabisulfite Drugs 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 229910000031 sodium sesquicarbonate Inorganic materials 0.000 description 1
- 235000018341 sodium sesquicarbonate Nutrition 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 239000011973 solid acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 125000005480 straight-chain fatty acid group Chemical group 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- WCTAGTRAWPDFQO-UHFFFAOYSA-K trisodium;hydrogen carbonate;carbonate Chemical compound [Na+].[Na+].[Na+].OC([O-])=O.[O-]C([O-])=O WCTAGTRAWPDFQO-UHFFFAOYSA-K 0.000 description 1
- 229940005605 valeric acid Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/22—Gas releasing
- A61K2800/222—Effervescent
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Description
本発明は新規な弱酸性入浴剤、更に詳細には、
炭酸塩と酸を含有し、使用時の浴湯PHが弱酸性を
呈する入浴剤に皮脂分泌促進剤を配合することに
より、血行促進効果及び皮膚のうるおいを相乗的
に高めた弱酸性入浴剤に関する。
入浴剤は一般に芒硝、硼砂、イオウ、食塩、炭
酸塩等の無機塩類混合物に香料、着色料、植物エ
キス、有機酸等を配合したもので、浴湯に香り、
色調を与えたり、皮膚面に適度な刺激を与えるこ
とにより血液の循環を活発にし、疲労回復、新陳
代謝を増進させるものである。これらの浴用剤の
中で、炭酸塩と酸を組合せた発泡性入浴剤があ
り、これは浴湯中に炭酸ガスの気泡を発生させ
て、リラツクス感や爽快感を高め、入浴を楽しく
する効果を有する。
しかしながら、従来の発泡性入浴剤は、中性な
いしは弱アルカリ性であつて、発生した炭酸ガス
のほとんど全ては水中に溶解せず、空気中に揮散
してしまうので、この炭酸ガスの気泡は単に感覚
的な機械的作用を奏するのみであつた。
そこで、本発明は、種々研究を行い、炭酸塩と
酸を含有し、浴湯のPHが弱酸性を呈する入浴剤と
することにより、炭酸ガスを浴液中に留め、血行
を促進し、湯冷めを惹起しない弱酸性入浴剤を開
発した。更に今般、本発明者は、これに皮脂分泌
促進剤を配合すると血行促進効果と皮膚のうるお
いが相乗的に高められることを見出し、本発明を
完成した。
すなわち、本発明は、炭酸塩と酸を含有する弱
酸性入浴剤において、皮脂分泌促進剤を配合した
弱酸性入浴剤を提供するものである。
本発明の弱酸性入浴剤に配合される炭酸塩とし
ては、例えば炭酸水素ナトリウム、炭酸ナトリウ
ム、セスキ炭酸ナトリウム、炭酸水素カリウム、
炭酸カリウム、セスキ炭酸カリウム、炭酸水素ア
ンモニウム塩、炭酸アンモニウム塩、セスキ炭酸
アンモニウム塩等が挙げられ、これらは単独又は
2種以上を組合わせて使用できる。
また、酸としては、有機酸及び無機酸の何れも
使用できるが、水溶性で固体のものが好ましい。
有機酸としては、例えばギ酸、酢酸、プロピオン
酸、酪酸、吉草酸等の直鎖脂肪酸;シユウ酸、マ
ロン酸、コハク酸、グルタル酸、アジピン酸、ピ
メリン酸、フマル酸、マレイン酸、フタル酸、イ
ソフタル酸、テレフタル酸等のジカルボン酸;グ
ルタミン酸、アスパラギン酸等の酸性アミノ酸;
グルコール酸、乳酸、ヒドロキシアクリル酸、α
―オキシ酪酸、グリセリン酸、タルトロン酸、リ
ンゴ酸、酒石酸、クエン酸、サリチル酸(o、
m、p)、没食子酸、マンデル酸、トロパ酸、ア
スコルビン酸、グルコン酸等のオキシ酸;桂皮
酸、安息香酸、フエニル酢酸、ニコチン酸、カイ
ニン酸、ソルビン酸、ピロリドンカルボン酸、ト
リメリツト酸、ベンゼンスルホン酸、トルエンス
ルホン酸並びにこれら有機酸の酸性塩が挙げられ
る。無機酸としては、例えば、リン酸、リン酸二
水素カリウム、リン酸二水素ナトリウム、亜硫酸
ナトリウム、亜硫酸カリウム、ピロ亜硫酸ナトリ
ウム(メタ重亜硫酸ナトリウム)、ピロ亜硫酸カ
リウム、(メタ重亜硫酸カリウム)酸性ヘキサメ
タリン酸ナトリウム、酸性ヘキサメタリン酸カリ
ウム、酸性ピロリン酸ナトリウム、酸性ピロリン
酸カリウム、スルフアミン酸等が挙げられる。就
中、コハク酸等の脂肪族ジカルボン酸、フマル
酸、リン酸及びこれらの酸性塩が好ましい。
更にまた、本発明で使用される皮脂分泌促進剤
の代表的なものとしては、次のものが挙げられ
る。
一般式()
(式中、Rは合計11〜23個の炭素原子を有し、
カルボキシル基結合位から主鎖の中央までに少
なくとも一つのアルキル置換基を有する飽和脂
肪族炭化水素基を示す)
で表わされる分岐脂肪酸コレステリルエステ
ル。
γ―オリザノール。
ヨクイニンもしくはヨクイニン抽出物で分子
量1500以下のもの。
尚分岐脂肪酸コレステリルエステルのうち、
()式中のRが、
(但し、mとnの和が14で、m=n=7を中心
とする分布を有する)
で表わされるものが好ましい。
ヨクイニン抽出物は次に示す方法のいずれか
により調製される。
(1) 生または乾燥ヨクイニンを50重量%(以下
単に%で示す)濃度以上のアルコール溶液で
抽出し、必要に応じて抽出液を過し、溶剤
を除去濃縮する。有効成分を効果的に抽出す
るためには、50〜80%濃度のエタノールを用
いることが望ましい。
(2) 生または乾燥ヨクイニンを水または50%濃
度以下のアルコール、アセトンなどの親水性
有機溶剤、または含水親水性有機溶剤で抽出
し、抽出液を過または遠心分離して、液
を採取する。必要に応じて溶剤を除去濃縮し
たのち、セフアデツクスなどの分子ふるいを
用い、ゲル過を行ない、分子量約1500以下
の画分を分取し、必要に応じて溶剤を除去濃
縮する。
(3) 生または乾燥ヨクイニンを水または50%濃
度以下のアルコール、アセトンなどの親水性
有機溶剤、または含水親水性有機溶剤で抽出
し、抽出液を過または遠心分離して液を
採取する。必要に応じて溶剤を除去濃縮した
のち、アルコールを添加し、最終濃度が50%
以上になるよう調製する。調製液を過また
は遠心分離して液を採取するが、必要に応
じて溶剤を除去濃縮する。有効成分を効果的
に抽出するためには、50〜80%濃度のエタノ
ールが望ましい。
上記抽出は冷浸又は温浸の何れによつてもな
し得るが、通常40〜70℃の温度で、数時間ない
し数日行うのが好ましい。
本発明弱酸性入浴剤の炭酸塩と酸の配合量は、
入浴剤を浴湯に加えたとき浴湯が弱酸性を呈する
ような比率、すなわち入浴剤の0.01重量%水溶液
がPH4〜7、特に好ましくはPH6.0〜6.7になるよ
うにすることが必要である。PHが4より低いと肌
への刺激が強いと共に風呂釜等をいためる惧れが
あり、またPHが7を超えると本発明の効果が奏さ
れない。
本発明の効果は、PHが酸性の場合には炭酸ガス
はCO2分子として存在して血流促進作用を示す
が、PHがアルカリ性側では炭酸ガスはCO3 2-イオ
ンあるいはHCO3 -イオンとして存在するため当
該効果は全く見られないという原理に基くもので
ある。
斯かる条件を具備するための炭酸塩と酸の配合
量は、これらの種類によつて異なるが、全組成に
対し、炭酸塩は5〜80重量%、特に10〜50%、酸
は10〜80%、特に15〜50%が好ましい。
また、皮脂分泌促進剤は、広い範囲の量で配合
できるが、一般には全組成に対し0.1〜5.0%、特
に0.5〜2.0%が好ましい。
更に、本発明入浴剤には、一般に配合されてい
る、香料、色素、あるいはビタミン類、温泉の有
効成分、蛋白分解酵素、海草エキス、アルギン酸
ナトリウム、ラノリン、シリコン、生薬あるいは
その抽出エキス等を配合して、効果を一層高める
ことができる。
本発明の弱酸性入浴剤は、粉末、顆粒、結晶、
錠剤等、特に好ましくは錠剤の形にすることがで
き、これらの製剤化のために、必要に応じて賦形
剤、結合剤、崩壊剤、滑沢剤等を添加することも
できる。
叙上の如く、本発明の弱酸性入浴剤はPHが人の
肌と大略同一であるので肌に好影響を与える。し
かも浴湯に投ずるとき発生する炭酸ガスは、アル
カリ性ではイオンとして存在するため血流促進効
果はないが、本発明の如く酸性領域ではCO2分子
として存在して肌の血行を促進する優れた効果を
奏する。
次に実施例を挙げて説明する。
実施例 1
第1表に示す組成の入浴剤を調製し、各入浴剤
を0.01%水溶液になるように浴湯に投入し、パネ
ラー30名に1ケ月間常法に従つて使用してもら
い、入浴剤としての全体評価(総合的な使用感)
湯冷めの有無及び皮膚のうるおい感を調べた。
The present invention provides a novel weakly acidic bath additive, more specifically,
Concerning a weakly acidic bath additive that synergistically enhances blood circulation promoting effects and skin moisture by incorporating a sebum secretion promoter into a bathing additive that contains carbonate and acid and exhibits a slightly acidic bath water PH when used. . Bath additives are generally a mixture of inorganic salts such as mirabilite, borax, sulfur, salt, carbonate, etc., combined with fragrances, colorants, plant extracts, organic acids, etc., and add fragrance to the bath water.
By adding color and moderate stimulation to the skin surface, it activates blood circulation, relieves fatigue, and improves metabolism. Among these bath additives, there are effervescent bath additives that combine carbonate and acid, which generate carbon dioxide gas bubbles in the bath water, increasing the feeling of relaxation and refreshment, and making bathing more enjoyable. has. However, conventional foaming bath additives are neutral or slightly alkaline, and almost all of the carbon dioxide gas generated does not dissolve in the water and evaporates into the air, so the carbon dioxide bubbles are simply a sensation. It had only a mechanical effect. Therefore, the present invention has been developed through various research, and by creating a bath additive that contains carbonate and acid and makes the PH of the bath water slightly acidic, it retains carbon dioxide gas in the bath liquid, promotes blood circulation, and cools the bath water. We have developed a weakly acidic bath additive that does not cause Furthermore, the present inventor has now completed the present invention by discovering that when a sebum secretion promoter is added to the composition, the blood circulation promoting effect and skin moisture are synergistically enhanced. That is, the present invention provides a weakly acidic bathing agent containing a carbonate and an acid, which contains a sebum secretion stimulant. Examples of carbonates to be added to the weakly acidic bath additives of the present invention include sodium hydrogen carbonate, sodium carbonate, sodium sesquicarbonate, potassium hydrogen carbonate,
Potassium carbonate, potassium sesquicarbonate, ammonium bicarbonate salt, ammonium carbonate salt, ammonium sesquicarbonate salt, etc. are mentioned, and these can be used alone or in combination of two or more kinds. Further, as the acid, both organic acids and inorganic acids can be used, but water-soluble and solid acids are preferred.
Examples of organic acids include straight chain fatty acids such as formic acid, acetic acid, propionic acid, butyric acid, and valeric acid; oxalic acid, malonic acid, succinic acid, glutaric acid, adipic acid, pimelic acid, fumaric acid, maleic acid, phthalic acid, Dicarboxylic acids such as isophthalic acid and terephthalic acid; acidic amino acids such as glutamic acid and aspartic acid;
Glycolic acid, lactic acid, hydroxyacrylic acid, α
- Oxybutyric acid, glyceric acid, tartronic acid, malic acid, tartaric acid, citric acid, salicylic acid (o,
m, p), oxyacids such as gallic acid, mandelic acid, tropic acid, ascorbic acid, gluconic acid; cinnamic acid, benzoic acid, phenylacetic acid, nicotinic acid, kainic acid, sorbic acid, pyrrolidonecarboxylic acid, trimellitic acid, benzene Examples include sulfonic acid, toluenesulfonic acid, and acid salts of these organic acids. Examples of inorganic acids include phosphoric acid, potassium dihydrogen phosphate, sodium dihydrogen phosphate, sodium sulfite, potassium sulfite, sodium metabisulfite, potassium metabisulfite, (potassium metabisulfite) acid hexamethalin Examples include sodium acid, potassium acid hexametaphosphate, sodium acid pyrophosphate, potassium acid pyrophosphate, and sulfamic acid. Among these, aliphatic dicarboxylic acids such as succinic acid, fumaric acid, phosphoric acid, and acid salts thereof are preferred. Furthermore, typical sebum secretion promoters used in the present invention include the following. General formula () (wherein R has a total of 11 to 23 carbon atoms,
A branched fatty acid cholesteryl ester represented by: a saturated aliphatic hydrocarbon group having at least one alkyl substituent from the carboxyl group bonding position to the center of the main chain. γ-oryzanol. Yokuinin or Yokuinin extract with a molecular weight of 1500 or less. Of the branched fatty acid cholesteryl esters, R in the formula () is (However, the sum of m and n is 14, and the distribution is centered at m=n=7.) Preferably, it is expressed as follows. Yokuinin extract is prepared by any of the following methods. (1) Extract raw or dried Yokuinin with an alcohol solution having a concentration of 50% by weight or higher (hereinafter simply expressed as %), and if necessary, filter the extract to remove the solvent and concentrate. In order to effectively extract the active ingredients, it is desirable to use ethanol at a concentration of 50-80%. (2) Extract raw or dried yokuinin with water or a hydrophilic organic solvent such as alcohol or acetone at a concentration of 50% or less, or a hydrophilic organic solvent containing water, and collect the liquid by filtering or centrifuging the extract. After removing and concentrating the solvent as necessary, gel filtration is performed using a molecular sieve such as Sephadex to separate a fraction with a molecular weight of about 1500 or less, and the solvent is removed and concentrated as necessary. (3) Extract fresh or dried yokuinin with water, alcohol with a concentration of 50% or less, a hydrophilic organic solvent such as acetone, or a water-containing hydrophilic organic solvent, and collect the liquid by filtering or centrifuging the extract. After removing the solvent and concentrating if necessary, add alcohol to reach a final concentration of 50%.
Adjust so that the amount is as follows. The prepared solution is filtered or centrifuged to collect the solution, and if necessary, the solvent is removed and concentrated. Ethanol at a concentration of 50-80% is desirable to effectively extract the active ingredients. The above-mentioned extraction can be carried out by either cold immersion or digestion, but it is usually preferable to carry out the extraction at a temperature of 40 to 70°C for several hours to several days. The amount of carbonate and acid in the weakly acidic bath additive of the present invention is as follows:
It is necessary to adjust the ratio so that when the bath additive is added to the bath water, the bath water exhibits weak acidity, that is, a 0.01% by weight aqueous solution of the bath additive has a pH of 4 to 7, particularly preferably PH 6.0 to 6.7. be. If the pH is lower than 4, there is a risk of strong skin irritation and damage to the bathtub, etc. If the pH is higher than 7, the effects of the present invention will not be achieved. The effect of the present invention is that when the pH is acidic, carbon dioxide gas exists as CO 2 molecules and exhibits a blood flow promoting effect, but when the pH is alkaline, carbon dioxide gas exists as CO 3 2- ions or HCO 3 - ions. This is based on the principle that the effect is not observed at all because the The blending amounts of carbonate and acid to satisfy these conditions vary depending on their type, but the carbonate should be 5 to 80% by weight, especially 10 to 50%, and the acid should be 10 to 50% by weight of the total composition. 80%, especially 15-50% is preferred. The sebum secretion promoter can be added in a wide range of amounts, but it is generally preferably 0.1 to 5.0%, particularly 0.5 to 2.0%, based on the total composition. Furthermore, the bath additives of the present invention contain commonly-used fragrances, pigments, vitamins, hot spring active ingredients, proteolytic enzymes, seaweed extracts, sodium alginate, lanolin, silicone, herbal medicines or their extracts, etc. The effect can be further enhanced. The weakly acidic bath additives of the present invention include powder, granules, crystals,
It can be made into a tablet, particularly preferably in the form of a tablet, and excipients, binders, disintegrants, lubricants, etc. can be added as necessary for the formulation thereof. As mentioned above, the weakly acidic bath additive of the present invention has a pH that is approximately the same as that of human skin, and therefore has a favorable effect on the skin. Moreover, the carbon dioxide gas generated when bath water is poured into bath water exists as ions in alkaline conditions and has no effect of promoting blood flow, but in acidic conditions as in the present invention, it exists as CO 2 molecules and has an excellent effect of promoting blood circulation in the skin. play. Next, an example will be given and explained. Example 1 Bath additives having the composition shown in Table 1 were prepared, each bath additive was added to bath water to make a 0.01% aqueous solution, and 30 panelists were asked to use it in the usual manner for one month. Overall evaluation as a bath additive (overall usability)
The presence or absence of cooling water and the feeling of moisture on the skin were examined.
【表】 その結果は第2表のとおりである。【table】 The results are shown in Table 2.
Claims (1)
て、皮脂分泌促進剤を配合したことを特徴とする
弱酸性入浴剤。 2 皮脂分泌促進剤が、一般式() (式中、Rは合計11〜23個の炭素原子を有し、カ
ルボキシル基結合位から主鎖の中央までに少なく
とも一つのアルキル置換基を有する飽和脂肪族炭
化水素基を示す) で表わされる分岐脂肪酸コレステリルエステル、
γ―オリザノール、またはヨクイニンもしく
はヨクイニン抽出物で分子量1500以下のものであ
る特許請求の範囲第1項記載の弱酸性入浴剤。[Scope of Claims] 1. A weakly acidic bathing agent containing a carbonate and an acid, characterized in that it contains a sebum secretion promoter. 2 The sebum secretion stimulant has the general formula () (In the formula, R represents a saturated aliphatic hydrocarbon group having a total of 11 to 23 carbon atoms and having at least one alkyl substituent from the carboxyl group bonding position to the center of the main chain.) fatty acid cholesteryl ester,
The weakly acidic bath additive according to claim 1, which is γ-oryzanol, or Yokuinin or Yokuinin extract, and has a molecular weight of 1500 or less.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59071507A JPS60215611A (en) | 1984-04-10 | 1984-04-10 | Weak-acidity bath preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59071507A JPS60215611A (en) | 1984-04-10 | 1984-04-10 | Weak-acidity bath preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS60215611A JPS60215611A (en) | 1985-10-29 |
JPS632927B2 true JPS632927B2 (en) | 1988-01-21 |
Family
ID=13462671
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP59071507A Granted JPS60215611A (en) | 1984-04-10 | 1984-04-10 | Weak-acidity bath preparation |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS60215611A (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07116017B2 (en) * | 1986-05-17 | 1995-12-13 | アース製薬株式会社 | Bath additive |
JP2527429B2 (en) * | 1986-12-08 | 1996-08-21 | エーザイ株式会社 | Bath salt |
JP5109113B2 (en) * | 2005-11-25 | 2012-12-26 | 国立大学法人 東京大学 | IgE scavenger and antiallergic pharmaceutical composition, cosmetic composition, food composition, beverage composition and feed composition |
-
1984
- 1984-04-10 JP JP59071507A patent/JPS60215611A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS60215611A (en) | 1985-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR940007919B1 (en) | Weakly acidic bath salt composition | |
JP2001206835A (en) | Collagen synthesis promoter and collagen metabolism activator | |
JP2004346045A (en) | Cosmetic additive, bathing agent and health food containing sake lees extract obtained in brewing of sake using deep seawater | |
JP2622574B2 (en) | Bath additive | |
JPS632927B2 (en) | ||
JPH0427206B2 (en) | ||
JPS5970609A (en) | Weakly acidic bathing agent | |
JPS61280417A (en) | Weakly acidic bath agent | |
JPH0545567B2 (en) | ||
JPS6064908A (en) | Cosmetic | |
JPH0233013B2 (en) | SOKONCHIRYOZAI | |
JPS60215621A (en) | Weak-acidity bath preparation | |
JPS60215613A (en) | Weak-acidity bath preparation | |
JPS60215618A (en) | Weak-acidity bath preparation | |
JP2004035425A (en) | Ameliorant for dropsy | |
JPH08766B2 (en) | Weakly acidic bath salt | |
JPH0558407B2 (en) | ||
JP3535985B2 (en) | Cosmetic pack and method for producing the same | |
JPS62249907A (en) | Cosmetic | |
JPS60215616A (en) | Weak-acidity bath preparation | |
JP2973368B2 (en) | Bath composition | |
JP2001226253A (en) | Bathing agent | |
JPH0512326B2 (en) | ||
JPH0334919A (en) | Bathing agent | |
JPS61225117A (en) | Weakly acidic bathing agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EXPY | Cancellation because of completion of term |